C
Chao Ju Ophthalmology
Chao Ju Ophthalmology is an ophthalmology treatment firm
About Chao Ju Ophthalmology
The story of Chao Ju Ophthalmology begins not in a boardroom, but with a family legacy of medicine dating back to 1921 when Zhang Xinghuan opened a clinic. This tradition was carried on by his son, Zhang Chaoju, who, after years of practicing medicine, often under basic conditions, focused his skills on ophthalmology. In 1988, with personal savings and borrowed funds, Zhang Chaoju established a small, 400-square-meter eye clinic in Baotou, Inner Mongolia, bearing his own name. This was the humble start of a focused enterprise dedicated to eye care. The company grew steadily under his leadership, establishing a reputation in the region. Following Zhang Chaoju's passing in 2012, his son, Zhang Bozhou, took the helm as chairman, continuing the family's vision. The business remains a family-run enterprise, with several of Zhang Chaoju's children and relatives involved in management and key medical roles. A pivotal moment for the company arrived on July 7, 2021, when Chao Ju Ophthalmology successfully launched its Initial Public Offering (IPO) on the Hong Kong Stock Exchange. This event provided significant capital, fueling a new phase of growth. The company has since pursued a strategy of expansion through acquisitions, adding numerous hospitals and clinics to its network across China, strengthening its position as a leading private ophthalmic group.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| FundingOther financing | Jun 2019 | $0 | — | Undisclosed | — |
| SERIES BOther financing | Jan 2019 | $59M | $237M | Riverhead Capital · Orchid Asia Group Management | — |
Growth signals
Latest recorded traffic for Chao Ju Ophthalmology is 240 monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Chao Ju Ophthalmology in its local ecosystem
The Chao Ju Ophthalmology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
- PVProsperico Ventures
Riverhead Capital
Orchid Asia Group Management
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Chao Ju Ophthalmology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Chao Ju Ophthalmology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









